Therefore, the beneficial effect of DHA to reduce TN expression may partly result from down-regulating SREBP-1c and FoxO, which could shed new light on preventive and therapeutic strategies for obesity-associated diseases. Here, SREBF1 is linked to obesity due to melanocortin 4 receptor deficiency.